Moderna shares are surging after a report the drugmaker confirmed it's working on a potential hantavirus vaccine. Several ...

These efforts are early-stage and ongoing and reflect Moderna’s broader responsibility to develop countermeasures against emerging infectious diseases,” the Cambridge-based company said.

After getting slapped with a surprise refuse-to-file letter signed by former CBER Director Vinay Prasad, Moderna’s flu ...

Moderna stock climbed after the deadly hantavirus outbreak drew investors' attention to the company's ongoing infectious disease efforts.

Moderna is in the early stages of developing a hantavirus vaccine, though its availability could be years away. Shares are up ~14% in Friday aft ...

Marjorie Taylor Greene and other conservative commentators have claimed that Moderna is developing a hantavirus mRNA vaccine.

Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing ...

Moderna stock rose 4% on Monday, extending its 12% rally on Friday. What’s behind the move: The biotech is researching ...

Moderna (NASDAQ:MRNA) shares climbed 10% on Thursday as concerns mounted over a hantavirus outbreak connected to a cruise ship.

RSV and flu mRNA vaccines struggle with lower durability, higher side effects, and weak uptake, leading to program cuts and ...

An experimental coronavirus vaccine is on its way to top health officials. Massachusetts-based biotech firm Moderna said Monday that it created its first batch of mRNA-1273 to treat humans for the ...